Associations Between Antidepressant Adherence and Shared Decision-Making, Patient–Provider Trust, and Communication Among Adults with Diabetes: Diabetes Study of Northern California (DISTANCE)
- 822 Downloads
Depression and adherence to antidepressant treatment are important clinical concerns in diabetes care. While patient–provider communication patterns have been associated with adherence for cardiometabolic medications, it is unknown whether interpersonal aspects of care impact antidepressant medication adherence.
To determine whether shared decision-making, patient–provider trust, or communication are associated with early stage and ongoing antidepressant adherence.
Observational new prescription cohort study.
Kaiser Permanente Northern California.
One thousand five hundred twenty-three adults with type 2 diabetes who completed a survey in 2006 and received a new antidepressant prescription during 2006–2010.
Exposures included items based on the Trust in Physicians and Interpersonal Processes of Care instruments and the Consumer Assessment of Healthcare Providers and Systems (CAHPS) communication scale. Measures of adherence were estimated using validated methods with physician prescribing and pharmacy dispensing data: primary non-adherence (medication never dispensed), early non-persistence (dispensed once, never refilled), and new prescription medication gap (NPMG; proportion of time without medication during 12 months after initial prescription).
After adjusting for potential confounders, patients’ perceived lack of shared decision-making was significantly associated with primary non-adherence (RR = 2.42, p < 0.05), early non-persistence (RR = 1.34, p < 0.01) and NPMG (estimated 5 % greater gap in medication supply, p < 0.01). Less trust in provider was significantly associated with early non-persistence (RRs 1.22–1.25, ps < 0.05) and NPMG (estimated NPMG differences 5–8 %, ps < 0.01).
All patients were insured and had consistent access to and quality of care.
Patients’ perceptions of their relationships with providers, including lack of shared decision-making or trust, demonstrated strong associations with antidepressant non-adherence. Further research should explore whether interventions for healthcare providers and systems that foster shared decision-making and trust might also improve medication adherence.
KEY WORDSmedication adherence antidepressive agents shared decision making trust physician–patient relations diabetes mellitus
- 9.Hudson DL, Karter AJ, Fernandez A, et al. Differences in the clinical recognition of depression in diabetes patients: the diabetes study of northern California (DISTANCE). Am J Manage Care. 2013;19(5):344–352.Google Scholar
- 13.American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Washington DC: American Psychiatric Association; 2010.Google Scholar
- 20.Agency for Health Care Policy and Research. CAHPS Health Plan Survey 4.0 Supplemental Items for the Adult Questionnaires https://cahps.ahrq.gov/surveys-guidance/item-sets/HP/1157a_engadultsupp_40.pdf. Accessed October 3, 2014.
- 31.Shin J, McCombs JS, Sanchez RJ, Udall M, Deminski MC, Cheetham TC. Primary nonadherence to medications in an integrated healthcare setting. Am J Manage Care. 2012;18(8):426–434.Google Scholar
- 34.DeWalt D, Callahan L, Hawk V, et al. Health literacy universal precautions toolkit (Prepared by North Carolina Network Consortium, The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, under Contract No. HHSA290200710014.) AHRQ Publication No. 10-0046-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2010.Google Scholar
- 36.Brach C, Keller D, Hernandez L, et al. Ten Attributes of Health Literate Health Care Organizations: National Academy of Sciences; 2012: http://iom.edu/~/media/Files/Perspectives-Files/2012/Discussion-Papers/BPH_Ten_HLit_Attributes.pdf. Accessed October 3, 2014.